阿片使用障碍孕妇围分娩期疼痛管理的范围综述
该范围综述由SOAP与SMFM联合完成,系统检索PubMed和Embase中关于阿片使用障碍(OUD)孕妇围分娩期疼痛管理的文献,共纳入84篇出版物,其中仅5项随机对照试验。现有证据多来自综述、意见和回顾性研究,原始研究不足6%,在非阿片镇痛、突破性疼痛阿片使用、椎管内镇痛优化等方面存在明显证据缺口。
要点
- OUD孕妇围分娩期疼痛管理证据等级低,原始研究不足6%。
- 缺乏试验证据的领域包括非阿片非药物镇痛及突破性疼痛阿片使用。
- 尚无文献讨论产房纳洛酮联开处方问题。
核心结论
- 关于OUD孕妇围分娩期疼痛管理的出版物数量在增加,但现有证据多处于证据金字塔低层级,亟需高质量原始研究指导临床。
研究设计与样本
- 范围综述,由SOAP与SMFM联合完成,系统检索PubMed和Embase所有语言文献,最终纳入84篇出版物进行全文审查。
主要发现
- 共导入994篇出版物筛选,最终84篇全文审查:32篇(38.1%)综述、14篇(16.7%)回顾性研究、8篇(9.5%)病例报告、5项随机对照试验。
- 大多数研究(64%)发表于围产学期刊(32篇;38.1%)或麻醉学期刊(22篇;26.2%)。
- 缺乏试验或系统综述证据的领域包括:优化心理社会共病的方法、替代非阿片及非药物镇痛方法、是否使用阿片治疗严重突破性疼痛及出院后处方监测、联合其他镇痛药时呼吸抑制和镇静监测、最佳椎管内镇痛剂量及辅助用药、剖宫产后腹壁阻滞的获益。
- 无出版物讨论产房环境中纳洛酮联开处方。
临床怎么用
- 临床应认识到OUD孕妇围分娩期疼痛管理缺乏高级别证据,现有意见存在冲突,需个体化决策。
局限性
- 现有文献多为综述、意见和回顾性研究,原始研究文章不足6%,证据等级低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prevalence of pregnant people with opioid use disorder (OUD), including those receiving medications for opioid use disorder (MOUD), is increasing. Challenges associated with pain management in people with OUD include tolerance, opioid-induced hyperalgesia, and risk for return to use. Yet, there are few evidence-based recommendations for pain management in the setting of pregnancy and the postpartum period, and many peripartum pain management studies exclude people with OUD. This scoping review summarized the available literature on peridelivery pain management in people with OUD, methodologies used, and identified specific areas of knowledge gaps. PubMed and Embase were comprehensively searched for publications in all languages on peripartum pain management among people with OUD, both treated with MOUD and untreated. Potential articles were screened by title, abstract, and full text. Data abstracted were descriptively analyzed to map available evidence and identify areas of limited or no evidence. A total of 994 publications were imported for screening on title, abstracts, and full text, yielding 84 publications identified for full review: 32 (38.1%) review articles, 14 (16.7%) retrospective studies, and 8 (9.5%) case reports. There were 5 randomized controlled trials. Most studies (64%) were published in perinatology (32; 38.1%) journals or anesthesiology (22; 26.2%) journals. Specific areas lacking trial or systematic review evidence include: (1) methods to optimize psychological and psychosocial comorbidities relevant to acute pain management around delivery; (2) alternative nonopioid and nonpharmacologic analgesia methods; (3) whether or not to use opioids for severe breakthrough pain and how best to prescribe and monitor its use after discharge; (4) monitoring for respiratory depression and sedation with coadministration of other analgesics; (5) optimal neuraxial analgesia dosing and adjuncts; and (6) benefits of abdominal wall blocks after cesarean delivery. No publications discussed naloxone coprescribing in the labor and delivery setting. We observed an increasing number of publications on peripartum pain management in pregnant people with OUD. However, existing published works are low on the pyramid of evidence (reviews, opinions, and retrospective studies), with a paucity of original research articles (<6%). Opinions are conflicting on the utility and disutility of various analgesic interventions. Studies generating high-quality evidence on this topic are needed to inform care for pregnant people with OUD. Specific research areas are identified, including utility and disutility of short-term opioid use for postpartum pain management, role of continuous wound infiltration and truncal nerve blocks, nonpharmacologic analgesia options, and the best methods to support psychosocial aspects of pain management.
引用
- Lim G, Soens M, Wanaselja A, et al. A Systematic Scoping Review of Peridelivery Pain Management for Pregnant People With Opioid Use Disorder: From the Society for Obstetric Anesthesia and Perinatology and Society for Maternal Fetal Medicine. Anesth Analg. 2022. PMID: 36135926. doi:10.1213/ANE.0000000000006167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。